Bluestar Genomics

Bluestar Genomics develops non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. We partnered with 22 Fillmore, a brand consultancy in the Bay Area, to deliver a full corporate rebrand that included a positioning platform, a new logo, identity system and company website among other touch points.